125 related articles for article (PubMed ID: 11377694)
21. Evaluation of a novel sodium borocaptate-containing unnatural amino acid as a boron delivery agent for neutron capture therapy of the F98 rat glioma.
Futamura G; Kawabata S; Nonoguchi N; Hiramatsu R; Toho T; Tanaka H; Masunaga SI; Hattori Y; Kirihata M; Ono K; Kuroiwa T; Miyatake SI
Radiat Oncol; 2017 Jan; 12(1):26. PubMed ID: 28114947
[TBL] [Abstract][Full Text] [Related]
22. Triple ionization chamber method for clinical dose monitoring with a Be-covered Li BNCT field.
Nguyen TT; Kajimoto T; Tanaka K; Nguyen CC; Endo S
Med Phys; 2016 Nov; 43(11):6049. PubMed ID: 27806584
[TBL] [Abstract][Full Text] [Related]
23. [Application of Gel Detector in Boron Neutron Capture Therapy].
Sakurai Y; Uchida R
Igaku Butsuri; 2017; 37(3):190-194. PubMed ID: 29415963
[TBL] [Abstract][Full Text] [Related]
24. Carborane-Containing Folic Acid
Gruzdev DA; Telegina AA; Levit GL; Solovieva OI; Gusel'nikova TY; Razumov IA; Krasnov VP; Charushin VN
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430206
[TBL] [Abstract][Full Text] [Related]
25. Insights into the use of gadolinium and gadolinium/boron-based agents in imaging-guided neutron capture therapy applications.
Deagostino A; Protti N; Alberti D; Boggio P; Bortolussi S; Altieri S; Crich SG
Future Med Chem; 2016 May; 8(8):899-917. PubMed ID: 27195428
[TBL] [Abstract][Full Text] [Related]
26. Carborane-conjugated 2-quinolinecarboxamide ligands of the translocator protein for boron neutron capture therapy.
Cappelli A; Valenti S; Mancini A; Giuliani G; Anzini M; Altieri S; Bortolussi S; Ferrari C; Clerici AM; Zonta C; Carraro F; Filippi I; Giorgi G; Donati A; Ristori S; Vomero S; Concas A; Biggio G
Bioconjug Chem; 2010 Dec; 21(12):2213-21. PubMed ID: 21087014
[TBL] [Abstract][Full Text] [Related]
27. Hydrophobic boron compound-loaded poly(l-lactide-co-glycolide) nanoparticles for boron neutron capture therapy.
Takeuchi I; Nomura K; Makino K
Colloids Surf B Biointerfaces; 2017 Nov; 159():360-365. PubMed ID: 28806667
[TBL] [Abstract][Full Text] [Related]
28. In vivo prompt gamma neutron activation analysis for the screening of boron-10 distribution in a rabbit knee: a simulation study.
Zhu X; Clackdoyle R; Shortkroff S; Yanch J
Phys Med Biol; 2008 May; 53(10):2715-32. PubMed ID: 18445874
[TBL] [Abstract][Full Text] [Related]
29. Synthesis of stable platinum complexes containing carborane in a carrier group for potential BNCT agents.
Yoo J; Do Y
Dalton Trans; 2009 Jul; (25):4978-86. PubMed ID: 19662290
[TBL] [Abstract][Full Text] [Related]
30. Solid state microdosimetry in hadron therapy.
Rosenfeld AB; Bradley PD; Cornelius I; Allen BJ; Zaider M; Maughan RL; Yanch JC; Coderre J; Flanz JB; Kobayashi T
Radiat Prot Dosimetry; 2002; 101(1-4):431-4. PubMed ID: 12382784
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics of core-polymerized, boron-conjugated micelles designed for boron neutron capture therapy for cancer.
Sumitani S; Oishi M; Yaguchi T; Murotani H; Horiguchi Y; Suzuki M; Ono K; Yanagie H; Nagasaki Y
Biomaterials; 2012 May; 33(13):3568-77. PubMed ID: 22326646
[TBL] [Abstract][Full Text] [Related]
32. Receptor-targeted liposomal delivery of boron-containing cholesterol mimics for boron neutron capture therapy (BNCT).
Thirumamagal BT; Zhao XB; Bandyopadhyaya AK; Naranyanasamy S; Johnsamuel J; Tiwari R; Golightly DW; Patel V; Jehning BT; Backer MV; Barth RF; Lee RJ; Backer JM; Tjarks W
Bioconjug Chem; 2006; 17(5):1141-50. PubMed ID: 16984121
[TBL] [Abstract][Full Text] [Related]
33. Exploiting Blood Transport Proteins as Carborane Supramolecular Vehicles for Boron Neutron Capture Therapy.
Marforio TD; Mattioli EJ; Zerbetto F; Calvaresi M
Nanomaterials (Basel); 2023 May; 13(11):. PubMed ID: 37299673
[TBL] [Abstract][Full Text] [Related]
34. Trivalent galactosyl-functionalized mesoporous silica nanoparticles as a target-specific delivery system for boron neutron capture therapy.
Lai CH; Lai NC; Chuang YJ; Chou FI; Yang CM; Lin CC
Nanoscale; 2013 Oct; 5(19):9412-8. PubMed ID: 23958787
[TBL] [Abstract][Full Text] [Related]
35. Boron neutron capture therapy of brain tumors: an emerging therapeutic modality.
Barth RF; Soloway AH; Goodman JH; Gahbauer RA; Gupta N; Blue TE; Yang W; Tjarks W
Neurosurgery; 1999 Mar; 44(3):433-50; discussion 450-1. PubMed ID: 10069580
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and in vitro evaluation of thiododecaborated α, α- cycloalkylamino acids for the treatment of malignant brain tumors by boron neutron capture therapy.
Hattori Y; Kusaka S; Mukumoto M; Ishimura M; Ohta Y; Takenaka H; Uehara K; Asano T; Suzuki M; Masunaga S; Ono K; Tanimori S; Kirihata M
Amino Acids; 2014 Dec; 46(12):2715-20. PubMed ID: 25173737
[TBL] [Abstract][Full Text] [Related]
37. Radiation dose heterogeneity in receptor and antigen mediated boron neutron capture therapy.
Hartman T; Carlsson J
Radiother Oncol; 1994 Apr; 31(1):61-75. PubMed ID: 8041899
[TBL] [Abstract][Full Text] [Related]
38. Monte Carlo-based treatment planning for boron neutron capture therapy using custom designed models automatically generated from CT data.
Zamenhof R; Redmond E; Solares G; Katz D; Riley K; Kiger S; Harling O
Int J Radiat Oncol Biol Phys; 1996 May; 35(2):383-97. PubMed ID: 8635948
[TBL] [Abstract][Full Text] [Related]
39. Nucleoside Scaffolds and Carborane Clusters for Boron Neutron Capture Therapy: Developments and Future Perspective.
Khalil A; Adam MSS
Curr Med Chem; 2023 Oct; ():. PubMed ID: 37818562
[TBL] [Abstract][Full Text] [Related]
40. The acceleration of boron neutron capture therapy using multi-linked mercaptoundecahydrododecaborate (BSH) fused cell-penetrating peptide.
Michiue H; Sakurai Y; Kondo N; Kitamatsu M; Bin F; Nakajima K; Hirota Y; Kawabata S; Nishiki T; Ohmori I; Tomizawa K; Miyatake S; Ono K; Matsui H
Biomaterials; 2014 Mar; 35(10):3396-405. PubMed ID: 24452095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
